112 related articles for article (PubMed ID: 8292449)
1. Basic evaluation of 67Ga labeled digoxin derivative as a metal-labeled bifunctional radiopharmaceutical.
Fujibayashi Y; Takemura Y; Taniuchi H; Iijima N; Konishi J; Yokoyama A
Ann Nucl Med; 1993 Nov; 7(4):239-44. PubMed ID: 8292449
[TBL] [Abstract][Full Text] [Related]
2. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
[TBL] [Abstract][Full Text] [Related]
3. 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Saga T; Konishi J; Yamamuro T
Cancer Res; 1988 Mar; 48(5):1189-94. PubMed ID: 3422590
[TBL] [Abstract][Full Text] [Related]
4. Development of Ga-67 labeled DFO-DAS-fibrinogen conjugate as a thrombus imaging agent.
Yamaoka S
Radiat Med; 1987; 5(5):151-3. PubMed ID: 3438481
[TBL] [Abstract][Full Text] [Related]
5. In vivo kinetics and thrombus accumulation of 67Ga-labeled urokinase.
Ohmomo Y; Yokoyama A; Yamauchi Y; Horiuchi K; Saji H; Tanaka C; Torizuka K
Int J Nucl Med Biol; 1985; 12(1):47-52. PubMed ID: 4008166
[TBL] [Abstract][Full Text] [Related]
6. Development of glycoside-bound radiopharmaceuticals: novel radioiodination method for digoxin.
Takemura Y; Fujibayashi Y; Dote N; Taniuchi H; Iijima N; Konishi J; Yokoyama A
Biol Pharm Bull; 1994 Jan; 17(1):97-101. PubMed ID: 8148823
[TBL] [Abstract][Full Text] [Related]
7. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
8. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
Mathias CJ; Wang S; Lee RJ; Waters DJ; Low PS; Green MA
J Nucl Med; 1996 Jun; 37(6):1003-8. PubMed ID: 8683292
[TBL] [Abstract][Full Text] [Related]
9. Colon carcinoma immunoscintigraphy by monoclonal anti-CEA antibody labeled with gallium-67-aminooxyacetyldeferroxamine.
Ryser JE; Jones RM; Egeli R; Pélegrin A; Rose K; Kurt AM; Perin M; Broquet PE; Ambrosetti P; Fisch I
J Nucl Med; 1992 Oct; 33(10):1766-73. PubMed ID: 1403142
[TBL] [Abstract][Full Text] [Related]
10. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
[TBL] [Abstract][Full Text] [Related]
11. High myocardial accumulation of radioiodinated digoxin derivative: a possible Na,K-ATPase imaging agent.
Fujibayashi Y; Takemura Y; Matsumoto K; Wada K; Yonekura Y; Konishi J; Yokoyama A
J Nucl Med; 1992 Apr; 33(4):545-9. PubMed ID: 1313082
[TBL] [Abstract][Full Text] [Related]
12. Succinylated polylysine as a possible link between an antibody molecule and deferoxamine.
Slinkin MA; Klibanov AL; Khaw BA; Torchilin VP
Bioconjug Chem; 1990; 1(4):291-5. PubMed ID: 2096922
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.
Wang S; Lee RJ; Mathias CJ; Green MA; Low PS
Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991
[TBL] [Abstract][Full Text] [Related]
14. Deferoxamine mesylate enhancement of 67Ga tumor-to-blood ratios and tumor imaging.
Koizumi K; Tonami N; Hisada K
Eur J Nucl Med; 1982; 7(5):229-33. PubMed ID: 6954069
[TBL] [Abstract][Full Text] [Related]
15. An antibody-desferrioxamine conjugate labelled with 67Ga.
Ward MC; Roberts KR; Babich JW; Bukhari MA; Coghlan G; Westwood JH; McCready VR; Ott RJ
Int J Rad Appl Instrum B; 1986; 13(5):505-7. PubMed ID: 3818312
[TBL] [Abstract][Full Text] [Related]
16. Digoxin derivatives with selectivity for the α2β3 isoform of Na,K-ATPase potently reduce intraocular pressure.
Katz A; Tal DM; Heller D; Habeck M; Ben Zeev E; Rabah B; Bar Kana Y; Marcovich AL; Karlish SJ
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13723-8. PubMed ID: 26483500
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
Hashmi M; Rosebrough SF
Drug Metab Dispos; 1995 Dec; 23(12):1362-7. PubMed ID: 8689944
[TBL] [Abstract][Full Text] [Related]
18. The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions.
Caraco C; Aloj L; Eckelman WC
Appl Radiat Isot; 1998 Dec; 49(12):1477-9. PubMed ID: 9745687
[TBL] [Abstract][Full Text] [Related]
19. Biological characterisation of [67Ga] or [68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors.
Stolz B; Smith-Jones PM; Albert R; Reist H; Mäcke H; Bruns C
Horm Metab Res; 1994 Oct; 26(10):453-9. PubMed ID: 7851867
[TBL] [Abstract][Full Text] [Related]
20. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]